|
|
|
|
|
|
Free Newsletters
Archive
My eNewsletters
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Login
Become a Member
Discussion Forums
FAQ
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Career Definitions
Labor Market Reports
Education & Training
Regions
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
Northstar Neuroscience, Inc. Announces Plan for NASDAQ Delisting and Filing of Articles of Dissolution
6/12/2009
SEATTLE, June 12, 2009 (GLOBE NEWSWIRE) -- Northstar Neuroscience, Inc. (Nasdaq:NSTR) announced today that is has provided written notice to The NASDAQ Stock Market, Inc. ("NASDAQ") of its intention to voluntarily delist its common stock from the NASDAQ Global Market. On June 22, 2009, Northstar will file with the Securities and Exchange Commission and NASDAQ a Form 25 relating to the delisting of Northstar's common stock. Northstar expects that trading in its common stock will be permanently suspended by NASDAQ effective at the open of trading on June 22, 2009, with official delisting of the common stock effective 10 days thereafter, on July 2, 2009, at which time Northstar's transfer agent will close the stock transfer records and discontinue recording transfers of the common stock.
|
|
|
|
|
|
|
|
|
|
|
|